Chen Au Peh
Overview
Explore the profile of Chen Au Peh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rovin B, Barratt J, Heerspink H, Alpers C, Bieler S, Chae D, et al.
Lancet
. 2023 Nov;
402(10417):2077-2090.
PMID: 37931634
Background: Sparsentan, a novel, non-immunosuppressive, single-molecule, dual endothelin angiotensin receptor antagonist, significantly reduced proteinuria versus irbesartan, an angiotensin II receptor blocker, at 36 weeks (primary endpoint) in patients with immunoglobulin...
2.
Smith R, Jones R, Specks U, Bond S, Nodale M, Al-Jayyousi R, et al.
Ann Rheum Dis
. 2023 Mar;
82(7):937-944.
PMID: 36958796
Objective: Following induction of remission with rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) relapse rates are high, especially in patients with history of relapse. Relapses are associated with increased exposure...
3.
Salehi T, Fleet A, Hissaria P, Carroll R, Peh C
Hum Immunol
. 2023 Jan;
84(3):196-198.
PMID: 36610806
Azathioprine (AZA) drug hypersensitivity reaction (DHR) is an uncommon yet potentially lethal condition that often goes unrecognised in patients with anti-Neutrophil Cytoplasmic Antibody (ANCA) associated vasculitis (AAV). We conducted a...
4.
Jayne D, Walsh M, Merkel P, Peh C, Szpirt W, Puechal X, et al.
Health Technol Assess
. 2022 Sep;
26(38):1-60.
PMID: 36155131
Background: Anti-neutrophil cytoplasm antibody-associated vasculitis is a multisystem, autoimmune disease that causes organ failure and death. Physical removal of pathogenic autoantibodies by plasma exchange is recommended for severe presentations, along...
5.
Egan A, Kronbichler A, Neumann I, Bettiol A, Carlson N, Cid M, et al.
Kidney Int Rep
. 2022 Aug;
7(8):1745-1757.
PMID: 35967106
The first European Vasculitis Society (EUVAS) meeting report was published in 2017. Herein, we report on developments in the past 5 years which were greatly influenced by the pandemic. The...
6.
Walsh M, Collister D, Zeng L, Merkel P, Pusey C, Guyatt G, et al.
BMJ
. 2022 Feb;
376:e064604.
PMID: 35217545
Objective: To assess the effects of plasma exchange on important outcomes in anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). Design: Systematic review and meta-analysis of randomised controlled trials. Eligibility Criteria: Randomised...
7.
Thein M, Rogers C, White J, Mahmood M, Weinstein S, Nwe M, et al.
Toxicon
. 2021 Sep;
203:66-73.
PMID: 34562496
Snakebite is an important problem in Myanmar. Regionally, bites by Eastern Russell's vipers, Daboia siamensis (Viperidae, Viperinae), and monocled cobras, Naja kaouthia are considered medically important, but those categorised as...
8.
Bose B, Badve S, Johnson D, Hawley C, Jha V, Reidlinger D, et al.
Nephrology (Carlton)
. 2021 Aug;
27(1):35-43.
PMID: 34392579
Aim: There is no clear consensus on how best to treat primary membranous nephropathy (PMN). This study aimed to ascertain prevailing views among nephrologists on their choice of immunosuppressive agents...
9.
White J, Mahmood M, Alfred S, Thwin K, Kyaw K, Zaw A, et al.
Toxicon X
. 2020 Aug;
1:100001.
PMID: 32831344
Snakebite is predominantly an occupational disease affecting poor rural farmers in tropical regions and was recently added to the World Health Organisation list of Neglected Tropical Diseases (NTD). We document...
10.
White J, Alfred S, Bates D, Mahmood M, Warrell D, Cumming R, et al.
Toxicon X
. 2020 Aug;
1:100002.
PMID: 32831343
The Myanmar Snakebite Project is an Australian government (Department of Foreign Affairs and Trade) supported foreign aid project in collaboration with the Myanmar government with the aim of improving outcomes...